Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Liver Diseases

  Free Subscription


1 Am J Pathol
1 Biochem Biophys Res Commun
2 BMC Cancer
3 BMC Gastroenterol
2 Br J Surg
1 Cancer Res
2 Dig Dis Sci
1 Endoscopy
1 Gastroenterology
3 Gut
16 Hepatology
1 Indian J Gastroenterol
1 J Clin Oncol
1 J Comput Assist Tomogr
1 J Gastroenterol Hepatol
20 J Hepatol
1 N Engl J Med
2 PLoS One
3 Radiology
1 Semin Liver Dis
1 Transplant Proc
1 Transplantation

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Pathol

  1. ZHANG Y, Liu Y, Huo W, He L, et al
    The Role of miRNA and Long Noncoding RNA in Cholestatic Liver Diseases.
    Am J Pathol. 2024;194:879-893.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  2. ZHANG S, Gao YF, Zhang K, Deng GR, et al
    Integrating network pharmacology and experimental validation reveals therapeutic effects of D-mannose on NAFLD through mTOR suppression.
    Biochem Biophys Res Commun. 2024;715:149999.
    PubMed         Abstract available

    BMC Cancer

  3. QIN Y, Tang C, Li J, Gong J, et al
    Liver cancer in China: the analysis of mortality and burden of disease trends from 2008 to 2021.
    BMC Cancer. 2024;24:594.
    PubMed         Abstract available

  4. XIAO Y, Deng W, Luo L, Zhu G, et al
    Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinoma.
    BMC Cancer. 2024;24:588.
    PubMed         Abstract available

    BMC Gastroenterol

  5. ZHANG Q, Yu T, Tan H, Shi H, et al
    Hepatic recruitment of myeloid-derived suppressor cells upon liver injury promotes both liver regeneration and fibrosis.
    BMC Gastroenterol. 2024;24:163.
    PubMed         Abstract available

  6. GUO Y, Dong S, Li M, Tao Y, et al
    A new model of portal vein thrombosis in rats with cirrhosis induced by partial portal vein ligation plus carbon tetrachloride and intervened with rivaroxaban.
    BMC Gastroenterol. 2024;24:161.
    PubMed         Abstract available

  7. CHEN X, Fu L, Zhu Z, Wang Y, et al
    Exploring the association between dietary fiber intake and hepatic steatosis: insights from NHANES.
    BMC Gastroenterol. 2024;24:160.
    PubMed         Abstract available

    Br J Surg

    Lesional liver biopsies: better treatments, better studies, better science.
    Br J Surg. 2024;111:znae063.

  9. DE GRAAFF MR, Hendriks TE, Wouters M, Nielen M, et al
    Assessing quality of hepato-pancreato-biliary surgery: nationwide benchmarking.
    Br J Surg. 2024;111:znae119.
    PubMed         Abstract available

    Cancer Res

  10. RETTIG AR, Ganesh K
    Cancer Cells Hijack Physiologic Metabolic Signals to Seed Liver Metastasis.
    Cancer Res. 2024;84:1548-1549.
    PubMed         Abstract available

    Dig Dis Sci

  11. IM KH, Saeed WK, Kim EB, Lee AH, et al
    Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis.
    Dig Dis Sci. 2024;69:1701-1713.
    PubMed         Abstract available

  12. DONG Y, Xu H, Zhang Z, Zhou Z, et al
    A Novel Nomogram for Predicting Early Rebleeding After Endoscopic Treatment of Esophagogastric Variceal Hemorrhage.
    Dig Dis Sci. 2024;69:1852-1862.
    PubMed         Abstract available


  13. OGURA T, Okuda A, Ueno S, Nishioka N, et al
    Endoscopic ultrasound-guided hepaticogastrostomy stent exchange using a novel spiral plastic stent.
    Endoscopy. 2024;56.


  14. CHANG M, Hammami MB, Sakiani S
    A Case of Hepatobiliary Challenges: Unraveling the Mystery of Bile Duct Disappearance.
    Gastroenterology. 2024 May 14:S0016-5085(24)04914.


  15. WEN J, Zhang X, Wong CC, Zhang Y, et al
    Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma.
    Gut. 2024 May 13:gutjnl-2023-331117. doi: 10.1136/gutjnl-2023-331117.
    PubMed         Abstract available

  16. ISRAELSEN M, Alvarez-Silva C, Madsen BS, Hansen CD, et al
    Impact of acute alcohol consumption on circulating microbiome in asymptomatic alcohol-related liver disease.
    Gut. 2024;73:1041-1044.

  17. GEIER A, Trost J, Wang K, Schmid C, et al
    PNPLA3 fatty liver allele was fixed in Neanderthals and segregates neutrally in humans.
    Gut. 2024;73:1008-1014.
    PubMed         Abstract available


  18. AFONSO MB, Marques V, van Mil SWC, Rodrigues CMP, et al
    Human liver organoids: From generation to applications.
    Hepatology. 2024;79:1432-1451.
    PubMed         Abstract available

  19. JIN Y, Shou Y, Lei Q, Du C, et al
    An entropy weight method to integrate big omics and mechanistically evaluate DILI.
    Hepatology. 2024;79:1264-1278.
    PubMed         Abstract available

  20. WANG A, Blackford AL, Behling C, Wilson LA, et al
    Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease.
    Hepatology. 2024;79:1381-1392.
    PubMed         Abstract available

  21. UMBAUGH DS, Nguyen NT, Curry SC, Rule JA, et al
    The chemokine CXCL14 is a novel early prognostic biomarker for poor outcome in acetaminophen-induced acute liver failure.
    Hepatology. 2024;79:1352-1364.
    PubMed         Abstract available

  22. SIDALI S, Borie R, Sicre de Fontbrune F, El Husseini K, et al
    Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.
    Hepatology. 2024;79:1365-1380.
    PubMed         Abstract available

  23. SCHMIDT KA, Simonetto DA
    The telomere tango: Liver disease in the genomic spotlight.
    Hepatology. 2024;79:1249-1251.

  24. ZHAO G, Ma Q, Yang H, Jiang H, et al
    Base editing of the mutated TERT promoter inhibits liver tumor growth.
    Hepatology. 2024;79:1310-1323.
    PubMed         Abstract available

  25. ENGSTROM A, Wintzell V, Melbye M, Svanstrom H, et al
    Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study.
    Hepatology. 2024;79:1401-1411.
    PubMed         Abstract available

  26. ABDELMALEK MF, Rinella ME
    Steatotic liver disease, a useful construct in primary care that doesn't upset the apple cart.
    Hepatology. 2024;79:1252-1254.

  27. HANSEN BE, Vandriel SM, Vig P, Garner W, et al
    Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA.
    Hepatology. 2024;79:1279-1292.
    PubMed         Abstract available

  28. YEH JG, Newsome PN
    Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study.
    Hepatology. 2024;79:1255-1257.

  29. CALZADILLA-BERTOT L, Jeffrey AW, Jeffrey GP
    Letter to the Editor: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease.
    Hepatology. 2024;79:E153-E154.

  30. LOMBARDI R, Dalbeni A, Mantovani A, Ravaioli F, et al
    Reply: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease.
    Hepatology. 2024;79:E155-E156.

  31. LI Z, Zhang Y, Li Y, Lan J, et al
    Letter to the Editor: Statins as potential confounding factors to investigate the association between the use of GLP-1 receptor agonists and risk of HCC.
    Hepatology. 2024;79:E169-E170.

  32. Hepatology Highlights.
    Hepatology. 2024;79:1239-1240.

  33. Erratum: Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3.
    Hepatology. 2024;79:E171-E172.

    Indian J Gastroenterol

  34. KUMAR S, Irtaza M, Patra BR, Rao PK, et al
    Clinical profile of adult and pediatric patients with hepatic Wilson's disease.
    Indian J Gastroenterol. 2024 May 10. doi: 10.1007/s12664-024-01586.
    PubMed         Abstract available

    J Clin Oncol

  35. FICHTINGER RS, Aldrighetti LA, Abu Hilal M, Troisi RI, et al
    Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial.
    J Clin Oncol. 2024;42:1799-1809.
    PubMed         Abstract available

    J Comput Assist Tomogr

  36. DI STASIO M, Cordopatri C, Nardi C, Busoni S, et al
    Liver Biliary Function Evaluation on a 1.5T Magnetic Resonance Imaging Scan by T1 Reduction Rate Assessment Using Variable-Flip-Angle Sequences.
    J Comput Assist Tomogr. 2024;48:354-360.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  37. LIU S, Gou H, Wei H, Chen S, et al
    Cholecystohepatic shunt pathway reduces secondary bile acid accumulation to enhance natural killer T cell-mediated anti-hepatocellular carcinoma immunity.
    J Gastroenterol Hepatol. 2024 May 15. doi: 10.1111/jgh.16548.
    PubMed         Abstract available

    J Hepatol

  38. YANG M, Zhang F, Liu K
    Cirrhosis Decompensation: Clinical and Prognostic Analysis from a New Perspective.
    J Hepatol. 2024 May 9:S0168-8278(24)00337-4. doi: 10.1016/j.jhep.2024.

  39. ZHANG Y, Xiao F, Xie R
    Healthy volunteer bias for the role of genetic risk in dietary effects on hepatic steatosis, inflammation and fibrosis.
    J Hepatol. 2024 May 9:S0168-8278(24)00335-0. doi: 10.1016/j.jhep.2024.

  40. NARDELLI S, Vizzutti F, Marra F, Schepis F, et al
    Can we really advise a patient undergoing TIPS that the onset of episodic hepatic encephalopathy will not influence his/her survival?
    J Hepatol. 2024 May 9:S0168-8278(24)00339-8. doi: 10.1016/j.jhep.2024.

  41. ZHU CX, Yan K, Chen L, Huang RR, et al
    Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8(+) T cells in hepatocellular carcinoma.
    J Hepatol. 2024 May 15:S0168-8278(24)00342-8. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available

  42. VARGHESE J, Chapiro J
    ChatGPT: The transformative influence of generative AI on science and healthcare.
    J Hepatol. 2024;80:977-980.
    PubMed         Abstract available

  43. ZHANG Y, Liu H, Sheng B, Tham YC, et al
    Preliminary fatty liver disease grading using general-purpose online large language models: ChatGPT-4 or Bard?
    J Hepatol. 2024;80:e279-e281.

  44. KRUK B, Liebe R, Weber SN, Milkiewicz P, et al
    ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort.
    J Hepatol. 2023 Nov 28:S0168-8278(23)05290-X. doi: 10.1016/j.jhep.2023.

  45. HE C, Lu D, Zheng S, Xu X, et al
    Liver disease is a significant risk factor for cardiovascular outcomes - A UK Biobank study.
    J Hepatol. 2024;80:e287-e288.

  46. HAHN M, Herber A, Berg T, Seehofer D, et al
    Enhancing HCC Recurrence Prediction after Liver Transplantation: from DCP plus AFP-L3 model to GALAD Score.
    J Hepatol. 2023 Dec 16:S0168-8278(23)05357-6. doi: 10.1016/j.jhep.2023.

  47. PANG Y, Aberg F, Chen Z, Li L, et al
    Predicting risk of chronic liver disease in Chinese adults: External validation of the CLivD score.
    J Hepatol. 2024;80:e264-e266.

  48. COLAPIETRO F, Akpinar R, Pugliese N, Di Tommaso L, et al
    Unexpected diagnosis in females with abnormal liver ultrasound.
    J Hepatol. 2024;80:e243-e245.

  49. DUIJZER R, Boerrigter MM, Gevers TJG, Drenth JPH, et al
    The pathophysiology of polycystic liver disease.
    J Hepatol. 2024;80:981-983.

  50. BROUWERS MCGJ, Cassiman D
    Rare monogenic causes of steatotic liver disease masquerading as MASLD.
    J Hepatol. 2024;80:e252-e253.

  51. HASHIDA R, Nakano D, Kawaguchi M, Younossi ZM, et al
    Changing from NAFLD to MASLD: The implications for health-related quality of life data.
    J Hepatol. 2024;80:e249-e251.

  52. NORMAN JS, Mehta N
    Reply to: "Enhancing HCC recurrence prediction after liver transplantation: From DCP plus AFP-L3 model to GALAD score".
    J Hepatol. 2024;80:e273-e274.

  53. DAI H, Zhu C, Huai Q, Xu W, et al
    Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models.
    J Hepatol. 2024;80:913-927.
    PubMed         Abstract available

  54. WU XN, Wang MZ, Zhang N, Zhang W, et al
    Sex-determining region Y gene promotes liver fibrosis and accounts for sexual dimorphism in its pathophysiology.
    J Hepatol. 2024;80:928-940.
    PubMed         Abstract available

  55. ZOU Z, Liu X, Yu J, Ban T, et al
    Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice.
    J Hepatol. 2024;80:834-845.
    PubMed         Abstract available

  56. CABIBBO G, Celsa C, Rimassa L, Torres F, et al
    Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice.
    J Hepatol. 2024;80:957-966.
    PubMed         Abstract available

  57. TANG R, Li Y, Chen R, Ma X, et al
    Reply to "ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort".
    J Hepatol. 2024 Jan 30:S0168-8278(24)00058-8. doi: 10.1016/j.jhep.2024.

    N Engl J Med

  58. NAJEM M, Dong E
    Esophageal Varices, White-Nipple Sign, and Portal Hypertensive Gastropathy.
    N Engl J Med. 2024;390:e47.

    PLoS One

  59. VATSYAYAN A, Kumar M, Saikia BJ, Scaria V, et al
    WilsonGenAI a deep learning approach to classify pathogenic variants in Wilson Disease.
    PLoS One. 2024;19:e0303787.
    PubMed         Abstract available

  60. OSAWA Y, Kawai H, Nakashima K, Nakaseko Y, et al
    Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis.
    PLoS One. 2024;19:e0303296.
    PubMed         Abstract available


  61. MENDIRATTA-LALA M, Fetzer D, Kamaya A, Parikh ND, et al
    The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance.
    Radiology. 2024;311:e232624.
    PubMed         Abstract available

  62. OZKAYA E, Kennedy P, Chen J, Bane O, et al
    Precision and Test-Retest Repeatability of Stiffness Measurement with MR Elastography: A Multicenter Phantom Study.
    Radiology. 2024;311:e233136.
    PubMed         Abstract available

  63. TANG A
    Liver Stiffness at MR Elastography: A Surrogate Biomarker for Staging Liver Fibrosis, Predicting Clinical Outcomes, and Selecting Patients.
    Radiology. 2024;311:e240890.

    Semin Liver Dis

  64. MA J, Bjornsson ES, Chalasani N
    Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment.
    Semin Liver Dis. 2024 May 13. doi: 10.1055/s-0044-1787062.
    PubMed         Abstract available

    Transplant Proc

  65. SILVA MS, Waisberg DR, Caldas TG, Martino RB, et al
    Life-Threatening Ruptured Hepatic Artery Pseudoaneurysm Post-Liver Transplant: A Case Report.
    Transplant Proc. 2024 May 13:S0041-1345(24)00256.
    PubMed         Abstract available


  66. CILLO U, Lauterio A, Furlanetto A, Canitano N, et al
    Full-left/Full-right Liver Splitting With Middle Hepatic Vein and Caval Partition During Dual Hypothermic Oxygenated Machine Perfusion.
    Transplantation. 2024 May 17. doi: 10.1097/TP.0000000000005039.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.